Published in Glycoconj J on June 24, 2003
IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest (2008) 2.15
Tumour-associated carbohydrate antigens in breast cancer. Breast Cancer Res (2010) 1.41
Regulation of the metastatic cell phenotype by sialylated glycans. Cancer Metastasis Rev (2012) 1.32
Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol (2012) 1.09
Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model. Br J Cancer (2009) 0.98
Biosynthetic Machinery Involved in Aberrant Glycosylation: Promising Targets for Developing of Drugs Against Cancer. Front Oncol (2015) 0.91
Protein modifications as potential biomarkers in breast cancer. Biomark Insights (2009) 0.87
Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation. Virchows Arch (2007) 0.85
RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells. Gastric Cancer (2014) 0.85
The androgen receptor controls expression of the cancer-associated sTn antigen and cell adhesion through induction of ST6GalNAc1 in prostate cancer. Oncotarget (2015) 0.85
Enhancement of metastatic ability by ectopic expression of ST6GalNAcI on a gastric cancer cell line in a mouse model. Clin Exp Metastasis (2012) 0.83
Application of microarrays to identify and characterize genes involved in attachment dependence in HeLa cells. Metab Eng (2006) 0.83
Challenges in Antibody Development against Tn and Sialyl-Tn Antigens. Biomolecules (2015) 0.82
CDX2 homeoprotein is involved in the regulation of ST6GalNAc-I gene in intestinal metaplasia. Lab Invest (2015) 0.77
Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions. Glycobiology (2016) 0.76
Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells. Int J Biol Sci (2017) 0.75
Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guérin (BCG) and to oxidative damage. Oncotarget (2017) 0.75
Glycosyltransferases. Structure, localization, and control of cell type-specific glycosylation. J Biol Chem (1989) 3.99
Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J (1997) 2.21
Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res (1989) 1.93
Possible roles of tumor-associated carbohydrate antigens. Cancer Res (1996) 1.90
Growth adaptation to methotrexate of HT-29 human colon carcinoma cells is associated with their ability to differentiate into columnar absorptive and mucus-secreting cells. Cancer Res (1990) 1.85
Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3. Cancer Res (1986) 1.84
MUC1 and cancer. Biochim Biophys Acta (1999) 1.60
Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells. Exp Cell Res (2002) 1.48
OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily. J Biol Chem (1999) 1.41
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res (1998) 1.32
Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. Eur J Biochem (1995) 1.31
Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol (1996) 1.27
Recombinant MUC1 probe authentically reflects cell-specific O-glycosylation profiles of endogenous breast cancer mucin. High density and prevalent core 2-based glycosylation. J Biol Chem (2002) 1.15
Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer. Br J Cancer (1994) 1.07
High density O-glycosylation on tandem repeat peptide from secretory MUC1 of T47D breast cancer cells. J Biol Chem (1999) 1.05
Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem Cell Biol (1996) 1.00
Cell surface-expressed Thomsen-Friedenreich antigen in colon cancer is predominantly carried on high molecular weight splice variants of CD44. Glycobiology (2001) 1.00
STn and prognosis in breast cancer. Oncology (2001) 0.95
Sialosyl-Tn antigen. Its distribution in normal human tissues and expression in adenocarcinomas. Am J Clin Pathol (1992) 0.95
Cloning and expression of a human gene encoding an N-acetylgalactosamine-alpha2,6-sialyltransferase (ST6GalNAc I): a candidate for synthesis of cancer-associated sialyl-Tn antigens. Glycobiology (1999) 0.95
Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine. Bone Marrow Transplant (2000) 0.93
Pathways of mucin O-glycosylation in normal and malignant rat colonic epithelial cells reveal a mechanism for cancer-associated Sialyl-Tn antigen expression. Biol Chem (2001) 0.89
Histopathological subtypes and prognosis of gastric cancer are correlated with the expression of mucin-associated sialylated antigens: Sialosyl-Lewis(a), Sialosyl-Lewis(x) and sialosyl-Tn. Tumour Biol (1998) 0.88
Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis. Virchows Arch (1995) 0.88
The prognostic significance of sialyl-Tn antigen in women treated with breast carcinoma treated with adjuvant chemotherapy. Cancer (1997) 0.88
Recombinant human interleukins IL-1alpha, IL-1beta, IL-4, IL-6, and IL-7 show different and specific calcium-independent carbohydrate-binding properties. J Biol Chem (2000) 0.86
Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast. Breast Cancer Res Treat (2001) 0.84
Molecular cloning and functional expression of human ST6GalNAc II. Molecular expression in various human cultured cells. Biochim Biophys Acta (2000) 0.84
Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV. Biochem J (2000) 0.84
The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study. Eur J Surg Oncol (2001) 0.82
Sialyl Tn antigen is an independent predictor of outcome in patients with gastric cancer. Int J Cancer (1996) 0.81
Expression of sialyl-Tn in breast cancer. Correlation with prognostic parameters. Pathol Res Pract (1996) 0.81
Adhesion of Human Breast Cancer Cells to Vascular Endothelium Mediated by Sialyl Lewis &supx; /E-selectin. Breast Cancer (1996) 0.80
Redefined substrate specificity of ST6GalNAc II: a second candidate sialyl-Tn synthase. Biochem Biophys Res Commun (2000) 0.80
Cloning and expression of cDNA for a human Gal(beta1-3)GalNAc alpha2,3-sialyltransferase from the CEM T-cell line. Eur J Biochem (1997) 0.80
Sialyl Tn antigen expression is associated with the prognosis of patients with advanced colorectal cancer. Hepatogastroenterology (1999) 0.80
Altered GalNAc-alpha-2,6-sialylation compartments for mucin-associated sialyl-Tn antigen in colorectal adenoma and adenocarcinoma. J Histochem Cytochem (2001) 0.78
Correlation between sialyl Tn antigen and lymphatic metastasis in patients with Borrmann type IV gastric carcinoma. Br J Cancer (1995) 0.78
Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy. Cancer Res (1994) 0.77
Expression of epitopes of the tumour-associated glycoprotein 72 and clinicopathological correlations in mammary carcinomas. Eur J Cancer (1994) 0.75
The human sialyltransferase family. Biochimie (2001) 2.39
Spontaneous dissection of the celiac artery. Ann Vasc Surg (2001) 2.22
[Damage control laparotomy for haemorragic abdominal trauma. A retrospective multicentric study about 109 cases]. Ann Chir (2003) 1.97
Changes in the K+ current-density of MCF-7 cells during progression through the cell cycle: possible involvement of a h-ether.a-gogo K+ channel. Receptors Channels (2001) 1.55
FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev (2000) 1.39
A gene from the variant surface glycoprotein expression site encodes one of several transmembrane adenylate cyclases located on the flagellum of Trypanosoma brucei. Mol Cell Biol (1992) 1.38
TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene (2009) 1.38
1994, the year of sialyltransferases. Glycobiology (1995) 1.37
ST6GalNAc I expression in MDA-MB-231 breast cancer cells greatly modifies their O-glycosylation pattern and enhances their tumourigenicity. Glycobiology (2005) 1.36
Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res (1998) 1.32
Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem (2001) 1.29
Autocrine induction of invasion and metastasis by tumor-associated trypsin inhibitor in human colon cancer cells. Oncogene (2008) 1.24
Reciprocal control of osteoblast/chondroblast and osteoblast/adipocyte differentiation of multipotential clonal human marrow stromal F/STRO-1(+) cells. J Cell Biochem (2001) 1.24
Specific expression of matrix metalloproteinases 1, 3, 9 and 13 associated with invasiveness of breast cancer cells in vitro. Clin Exp Metastasis (2000) 1.19
Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells. Cancer Res (2001) 1.18
Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs. J Biol Chem (1998) 1.16
Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells. Oncogene (2011) 1.13
Normal matrix mineralization induced by strontium ranelate in MC3T3-E1 osteogenic cells. Metabolism (2004) 1.11
Involvement of glycosylation in the intracellular trafficking of glycoproteins in polarized epithelial cells. Biochimie (2003) 1.09
Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Oncogene (1998) 1.09
Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells. Int J Biochem Cell Biol (2009) 1.08
GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells. J Cell Biol (1998) 1.06
Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J Bone Miner Res (2001) 1.01
Cathepsin B, L, and D activities in colorectal carcinomas: relationship with clinico-pathological parameters. Cancer Lett (1995) 1.01
Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells. Br J Rheumatol (1997) 1.01
Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. J Cell Biochem (2001) 1.00
Immunohistochemical study of p53 in human lung carcinomas. Am J Pathol (1993) 0.99
Tumour growth and resistance to gemcitabine of pancreatic cancer cells are decreased by AP-2alpha overexpression. Br J Cancer (2009) 0.99
Expression of c-ets-1, collagenase 1, and urokinase-type plasminogen activator genes in lung carcinomas. Am J Pathol (1995) 0.99
Increased bone formation and decreased osteocalcin expression induced by reduced Twist dosage in Saethre-Chotzen syndrome. J Clin Invest (2001) 0.98
Behavior of human osteoblastic cells on stoichiometric hydroxyapatite and type A carbonate apatite: role of surface energy. J Biomed Mater Res (2000) 0.98
The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp Cell Res (2000) 0.97
Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21(waf1). Exp Cell Res (2004) 0.96
Identification of two novel conserved amino acid residues in eukaryotic sialyltransferases: implications for their mechanism of action. Glycobiology (1997) 0.96
Tamoxifen and TRAIL synergistically induce apoptosis in breast cancer cells. Oncogene (2007) 0.95
Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection. Eur J Surg Oncol (2012) 0.94
Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer. Clin Cancer Res (2000) 0.94
The c-Ha-ras oncogene induces increased expression of beta-galactoside alpha-2, 6-sialyltransferase in rat fibroblast (FR3T3) cells. Glycobiology (1992) 0.94
Specific secretion of gel-forming mucins and TFF peptides in HT-29 cells of mucin-secreting phenotype. Biochim Biophys Acta (2001) 0.94
Proteomic detection of changes in protein synthesis induced by fibroblast growth factor-2 in MCF-7 human breast cancer cells. Exp Cell Res (2001) 0.93
Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation. Glycoconj J (1996) 0.91
Multiplex RT-PCR method for the analysis of the expression of human sialyltransferases: application to breast cancer cells. Glycoconj J (1998) 0.91
O-glycosylation potential of lepidopteran insect cell lines. Biochim Biophys Acta (1999) 0.91
Characterization of mucins and proteoglycans synthesized by a mucin-secreting HT-29 cell subpopulation. J Cell Sci (1995) 0.90
Differential effect of GalNAcalpha-O-bn on intracellular trafficking in enterocytic HT-29 and Caco-2 cells: correlation with the glycosyltransferase expression pattern. J Cell Sci (2001) 0.90
Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating. Mol Pharmacol (2001) 0.89
p53 genetic abnormalities and myc activation in human lung carcinoma. Int J Cancer (1994) 0.89
Cysteine and serine proteases of synovial tissue in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol (2007) 0.89
Pharmacological effects of the lipidosterolic extract of Serenoa repens (Permixon) on rat prostate hyperplasia induced by hyperprolactinemia: comparison with finasteride. Prostate (2000) 0.88
Increased osteoblast apoptosis in apert craniosynostosis: role of protein kinase C and interleukin-1. Am J Pathol (2001) 0.88
Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependence. Am J Physiol Endocrinol Metab (2001) 0.88
Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion. Biochem J (1998) 0.86
Delineation of the minimal catalytic domain of human Galbeta1-3GalNAc alpha2,3-sialyltransferase (hST3Gal I). Biochim Biophys Acta (2001) 0.85
Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells. Prostate (2000) 0.85
Increased expression of protein kinase Calpha, interleukin-1alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray. J Bone Miner Res (2001) 0.84
Prognostic value of p53 and urokinase-type plasminogen activator in node-negative human breast cancers. Clin Cancer Res (1998) 0.84
Molecular cloning and functional expression of human ST6GalNAc II. Molecular expression in various human cultured cells. Biochim Biophys Acta (2000) 0.84
Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV. Biochem J (2000) 0.84
Successful renal transplantation in Jeune syndrome type 2. Pediatr Nephrol (1998) 0.83
Alkyl-lysophospholipid 1-O-octadecyl-2-O-methyl- glycerophosphocholine induces invasion through episialin-mediated neutralization of E-cadherin in human mammary MCF-7 cells in vitro. Int J Cancer (2001) 0.83
Massive in vitro synthesis of tagged oligosaccharides in 1-benzyl-2-acetamido-2-deoxy-alpha-D-galactopyranoside treated HT-29 cells. Glycobiology (2000) 0.82
Alteration of sialyl Lewis epitope expression in pterygium. Invest Ophthalmol Vis Sci (1999) 0.82
Study of the in vitro activity of amoxicillin/clavulanic acid and other beta-lactam antibiotics against Escherichia coli isolated from urine specimens. Acta Clin Belg (2001) 0.82
Microheterogeneity of the oligosaccharides carried by the recombinant bovine lactoferrin expressed in Mamestra brassicae cells. Glycobiology (1997) 0.82
Heterozygous M3Mmalton alpha1-antitrypsin deficiency associated with end-stage liver disease: case report and review. Clin Chem (2001) 0.80
Differential expression of sialic acid on porcine organs during the maturation process. Comp Biochem Physiol B Biochem Mol Biol (2000) 0.80
Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patients. Int J Biol Markers (2003) 0.80
Cloning and expression of cDNA for a human Gal(beta1-3)GalNAc alpha2,3-sialyltransferase from the CEM T-cell line. Eur J Biochem (1997) 0.80
[Value of celiac arteriography for the diagnosis of occult ruptures of the spleen. Apropos of 3 cases]. Lyon Chir (1972) 0.80
Altered glycosylation of membrane glycoproteins in human uroepithelial cell lines. Int J Cancer (1986) 0.80
N-glycosylation potential of maize: the human lactoferrin used as a model. Glycoconj J (2001) 0.79
Regulation of sialyltransferase expression by estradiol and 4-OH-tamoxifen in the human breast cancer cell MCF-7. Mol Cell Biol Res Commun (2000) 0.79
Transcriptional induction of beta-galactoside alpha-2,6-sialyltransferase in rat fibroblast by dexamethasone. Eur J Biochem (1993) 0.79